Koert P. de Jong - Concepedia

Author

Koert P. de Jong

University Medical Center Groningen ORCID

Also Known As

De Jong, Koert P., Egbert Sieders, J G van den Berg, John J. Hermans, K P De Jong, K P Jong, K P de Jong, K P. De Jong, K P. de Jong, K. Jong

256

Publications

8.7K

Citations

H-Index

111

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Radboud University Nijmegen Radboud University Medical Center University Medical Center Utrecht

About

Koert P. de Jong is an author at University Medical Center Groningen specializing in medicine, hepatology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	49	2.5K
2	Health Sciences	10	12	266
3	Natural Sciences	2	2	113
4	Engineering	1	1	66
5	Public Health	1	1	52

Koert P. de Jong

135

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke, Transplantation	2015	409
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS) Timothy H. Mungroop, L. Bengt van Rijssen, David van Klaveren, Annals of Surgery	2017	384
Anastomotic biliary strictures after liver transplantation: Causes and consequences Robert C. Verdonk, Carlijn I. Buis, Robert J. Porte, Liver Transplantation Transplantation SurgeryUrologyIntestinal TransplantationHepatologyMore Stents	2006	312
Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands Marloes A.G. Elferink, Koert P. de Jong, Joost M. Klaase, International Journal of Colorectal Disease Surgical OncologyMedicineColorectal CancerPathologyCancer Registration	2014	198
Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with <sup>18</sup>F-FDG PET: A Randomized Study Theo J. M. Ruers, Bastiaan Wiering, Joost R.M. van der Sijp, Journal of Nuclear Medicine	2009	171
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb, BMC Cancer	2010	159
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, The Lancet Oncology Surgical OncologyHepatologyMedicineHepatobiliary TumorColorectal Cancer	2023	153
Early vascular complications after pediatric liver transplantation Egbert Sieders, Paul Peeters, Elisabeth M. TenVergert, Liver Transplantation Solid Organ TransplantationTransplantation MedicineVascular ComplicationsSurgeryPediatric Liver Transplantation	2000	148
Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases Jana Hof, Marieke W.J.L.A.E. Wertenbroek, Paul Peeters, British journal of surgery	2016	140
Management of Severe Pancreatic Fistula After Pancreatoduodenectomy F. Jasmijn Smits, Hjalmar C. van Santvoort, Marc G. Besselink, JAMA Surgery	2017	137

Page 1